Equity Components [Axis]
Preferred Stock [Member]
Class of Stock [Axis]
Series J Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Antidilutive Securities [Axis]
Warrant [Member]
Share-Based Payment Arrangement, Option [Member]
Product and Service [Axis]
Direct Sales to Wholesalers [Member]
Indirect Sales to Wholesalers [Member]
ANDA Revenue [Member]
Licensing [Member]
Scheduled Products Manufacturing Fees [Member]
Scheduled Products Licensing Fees [Member]
Unscheduled Products Manufacturing Fees [Member]
Unscheduled Products Licensing Fees [Member]
Long-Lived Asset, Class [Axis]
Land, Buildings and Improvements [Member]
Laboratory, Manufacturing, Warehouse and Transportation Equipment [Member]
Office Equipment and Software [Member]
Furniture and Fixtures [Member]
Intangible Asset, Finite-Lived, Class [Axis]
ANDA Acquisition Costs [Member]
Patent Application Costs [Member]
Long-Term Debt, Type [Axis]
Njeda Bonds Series A Notes [Member]
Njeda Bonds Series B Notes [Member]
NJEDA Bonds [Member]
Njeda Bonds Current [Member]
Njeda Bonds Noncurrent [Member]
Mortgage Loan [Member]
Loans Payable [Member]
Related and Nonrelated Parties [Axis]
Nasrat Hakim CEO and Chairman [Member]
Debt Instrument Period [Axis]
First Year [Member]
Davis Caskey [Member]
Second Year [Member]
NBV Pompano Office Lease [Member]
140 Ludlow Lease [Member]
Water Equipment Lease [Member]
Warehouse Equipment Lease [Member]
February 2024 Equipment Lease [Member]
March 2024 Equipment Lease [Member]
July 2024 Equipment Lease [Member]
Other Lease [Member]
Nature of Expense [Axis]
Ludlow-144 [Member]
NBV-610 [Member]
Series J Convertible Preferred Stock [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Exercise Price [Member]
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Financial Instrument [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Plan Name [Axis]
2014 Equity Incentive Plan [Member]
2024 Equity Incentive Plan [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
Two Customers [Member]
Customer One [Member]
Customer Two [Member]
Three Customers [Member]
Customer Three [Member]
Accounts Receivable [Member]
Purchases [Member]
Supplier Concentration Risk [Member]
Three Suppliers [Member]
Supplier One [Member]
Supplier Two [Member]
Supplier Three [Member]
Segments [Axis]
Abbreviated New Drug Applications [Member]
Mikah Pharma LLC [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash
Accounts receivable, net of allowance for expected credit losses of $1,280,030 and $1,441,523 respectively
Inventory
Prepaid expenses and other current assets
Total current assets
Property and equipment, net of accumulated depreciation of $18,353,218 and $18,100,243 respectively
Intangible assets
Finance lease - right-of-use asset, net of accumulated amortization of $1,099,587 and $984,801 respectively
Operating lease - right-of-use asset
Deferred income tax asset
Other assets:
Restricted cash - debt service for NJEDA bonds
Security deposits
Total other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Bonds payable, current portion, net of bond issuance costs
Loans payable, current portion
Lease obligation - finance lease, current portion
Lease obligation - operating lease, current portion
Derivative financial instruments - warrants
Total current liabilities
Long-term liabilities:
Bonds payable, net of current portion and bond issuance costs
Loans payable, net of current portion and loan costs
Lease obligation - finance lease, net of current portion
Lease obligation - operating lease, net of current portion
Derivative financial instruments - warrants
Total long-term liabilities
Total liabilities
Commitments and Contingencies (Note 9)
Shareholders’ equity:
Common Stock; par value $0.001; 1,445,000,000 shares authorized; 1,077,236,442 and 1,077,196,442 shares issued as of June 30, 2026 and March 31, 2026, respectively; 1,077,136,442 and 1,077,096,442 shares outstanding as of June 30, 2026 and March 31, 2026 respectively
Additional paid-in capital
Treasury stock; 100,000 shares as of both June 30, 2026 and March 31, 2026 at cost
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity
Allowance for expected credit loss
Accumulated depreciation, property and equipment
Accumulated amortization, finance lease
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Revenue
Cost of manufacturing
Gross profit
Operating expenses:
Research and development
General and administrative
Non-cash compensation through issuance of stock options
Depreciation and amortization
Total operating expenses
Income from operations
Other income (expense):
Change in fair value of derivative financial instruments - warrants
Interest expense and amortization of debt issuance costs
Interest income
Other income (expense), net
Income (loss) before income taxes
Income tax expense
Net income (loss)
Basic net income (loss) per share
Diluted net income (loss) per share
Basic weighted average common stock outstanding
Diluted weighted average common stock outstanding
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Balance, treasury shares
Net income (loss)
Non-cash compensation through the issuance of employee stock options
Shares issued pursuant to exercise of employee stock options
Shares issued pursuant to exercise of employee stock options, shares
Balance
Balance, shares
Balance, treasury shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
(Recovery) provision for losses on accounts receivable
Amortization of operating leases - right-of-use assets
Amortization of finance leases - right-of-use assets
Amortization of debt discount - bonds offering costs
Change in fair value of derivative financial instruments - warrants
Deferred tax expense
Non-cash compensation through the issuance of employee stock options
Change in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Deferred revenue
Lease obligations - operating leases
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of related party loans payable
Payments on principal on finance lease obligations
Proceeds from exercise of stock options
Loan payments
Net cash used in financing activities
Net change in cash and restricted cash
Cash and restricted cash, beginning of period
Cash and restricted cash, end of period
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest
Cash paid for income taxes
Reconciliation of cash and restricted cash
Cash
Restricted cash - debt service for NJEDA bonds
Total cash and restricted cash shown in statement of cash flows
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Type [Axis]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Inventory Disclosure [Abstract]
INVENTORY
Property, Plant, and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
Payables and Accruals [Abstract]
ACCRUED EXPENSES
Debt Disclosure [Abstract]
NJEDA BONDS
LOANS PAYABLE
Related Party Transactions [Abstract]
RELATED PARTY LOANS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Equity [Abstract]
PREFERRED STOCK
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS – WARRANTS
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION
Risks and Uncertainties [Abstract]
CONCENTRATIONS AND CREDIT RISK
Segment Reporting [Abstract]
SEGMENT RESULTS
Related Party Agreements
RELATED PARTY AGREEMENTS
Income Tax Disclosure [Abstract]
INCOME TAXES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of Estimates
Segment Information
Revenue Recognition
Nature of goods and services
Disaggregation of revenue
Restricted Cash
Income Taxes
Earnings (Loss) Per Share
Recently Issued Accounting Pronouncements - Adopted
Recently Issued Accounting Pronouncements - Not Yet Adopted
SCHEDULE OF DISAGGREGATION OF REVENUE
SCHEDULE OF EARNINGS (LOSS) PER SHARE APPLICABLE TO COMMON SHAREHOLDERS
SCHEDULE OF INVENTORY
SCHEDULE OF PROPERTY AND EQUIPMENT
SCHEDULE OF INTANGIBLE ASSETS
SCHEDULE OF ACCRUED EXPENSES
SCHEDULE OF BONDS PAYABLE LIABILITY
SCHEDULE OF MATURITIES OF BONDS
SCHEDULE OF LOANS PAYABLE
SCHEDULE OF LOAN PRINCIPAL PAYMENTS
SCHEDULE OF RENT EXPENSE STRAIGHT-LINE BASIS
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS
SCHEDULE OF WEIGHTED -AVERAGE REMAINING TERM AND THE WEIGHTED-AVERAGE DISCOUNT RATE
SCHEDULE OF FAIR VALUE OF WARRANTS ISSUED
SCHEDULE OF CHANGES IN WARRANTS MEASURED AT FAIR VALUE ON A RECURRING BASIS
SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE ON A RECURRING BASIS
SCHEDULE OF STOCK OPTION PLAN
SCHEDULE OF SELECTED INFORMATION FOR REPORTABLE SEGMENTS
SCHEDULE OF OPERATING INCOME BY SEGMENT TO INCOME FROM OPERATIONS
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Total Revenue
Net income (loss) - basic
Effect of dilutive instrument on net income
Net income (loss) - diluted
Weighted average shares of Common Stock outstanding - basic
Dilutive effect of stock options and convertible securities
Weighted average shares of Common Stock outstanding - diluted
Net income (loss) per share
Basic
Diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of operating segment
Number of reportable segment
Restricted cash equivalents
Description of tax benefits
Conversion of warrants and options into common stock
Finished goods
Work-in-progress
Raw materials
Inventory
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross
Less: Accumulated depreciation
Property and equipment, net
Depreciation expense
Intangible Asset, Finite-Lived [Table]
Intangible Asset, Finite-Lived [Line Items]
Estimated Useful Life
Gross Carrying Amount
Additions
Impairment losses
Accumulated Amortization
Net Book Value
Co-development profit split
Employee bonuses
Income tax
Legal and professional expense
Audit fees
Director dues
Salaries and fees payable
Other accrued expenses
Total accrued expenses
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
NJEDA Bonds - Series A Notes
Less: Current portion of bonds payable (prior to deduction of bond offering costs)
Long term portion of bonds payable
Bond offering costs
Less: Accumulated amortization
Bond offering costs, net
Current portions of bonds payable
Less: Bonds offering costs to be amortized in the next 12 months
Current portion of bonds payable, net of bond offering costs
Less: Bond offering costs to be amortized subsequent to the next 12 months
Long term portion of bonds payable, net of bond offering costs
Remainder of 2027
2028
2029
2030
2031
Total
Mortgage loan payable 4.75% interest and maturing June 2032
Less: Current portion of loans payable
Long-term portion of loans payable
Mortgage loan interest rate
Borrowings
Interest rate stated percentage
Principal amount
Maturity date
Annual interest rate
Amortization expense
Interest payable
Interest expense
Thereafter
Interest expense loans payable
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Notes payable
Promissory note, interest rate
Interest expense, short term borrowings
Interim Period, Costs Not Allocable [Table]
Interim Period, Costs Not Allocable [Line Items]
Rent expense
Operating Lease Amount, 2027
Financing Lease Amount, 2027
Total Lease Amount, 2027
Operating Lease Amount 2028
Financing Lease Amount 2028
Total Lease Amount 2028
Operating Lease Amount 2029
Financing Lease Amount 2029
Total Lease Amount 2029
Operating Lease Amount 2030
Financing Lease Amount 2030
Total Lease Amount 2030
Operating Lease Total future minimum lease payments
Financing Lease Total future minimum lease payments
Total future minimum lease payments
Operating Lease Amount Less: interest
Financing Lease Amount Less: interest
Total Lease Amount Less: interest
Operating Lease Amount Present value of lease payments
Financing Lease Amount Present value of lease payments
Total Lease Amount Present value of lease payments
Remaining lease term (years) Operating leases
Remaining lease term (years) Finance leases
Discount rate Operating leases
Discount rate Finance leases
Operating lease term
Lease expiration date
Finance lease acquisition cost
Finance lease purchase of asset
Finance lease term
Finance lease expire
Finance lease option to terminate
Description of lessee's finance lease
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Preferred stock, share authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Convertible preferred stock stated value
Convertible preferred stock par value per share
Business Combination [Table]
Business Combination [Line Items]
Warrants and rights outstanding, measurement input
Warrant term (in years)
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Beginning balance
Ending balance
Derivative liabilities, beginning balance
Change in fair value of derivative instruments
Derivative liabilities, ending balance
Reclassification out of Accumulated Other Comprehensive Income [Table]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Warrant term
Warrant to purchase shares
Weighted Average Exercise Price
Shares Underlying Options, Outstanding, Beginning Balance
Weighted Average Exercise Price, Outstanding, Beginning Balance
Weighted Average Remaining Contractual Term (in years), Outstanding
Aggregate Intrinsic Value, Outstanding, Beginning Balance
Shares Underlying Options, Granted
Weighted Average Exercise Price, Granted
Shares Underlying Options, Exercised
Weighted Average Exercise Price, Exercised
Shares Underlying Options, Expired and Forfeited
Weighted Average Exercise Price, Expired and Forfeited
Shares Underlying Options, Outstanding, Ending Balance
Weighted Average Exercise Price, Outstanding, Ending Balance
Aggregate Intrinsic Value, Outstanding, Ending Balance
Shares Underlying Options, Exercisable
Weighted Average Exercise Price, Exercisable
Weighted Average Remaining Contractual Term (in years), Exercisable
Aggregate Intrinsic Value, Outstanding, Exerciseable
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Increase in shares reserved
Options available for grant
Price difference between exercise price and quoted price
Unrecognized stock based compensation expense
Weighted average period
Concentration Risk [Table]
Concentration Risk [Line Items]
Concentration risk, percentage
Segment Reporting [Table]
Segment Reporting [Line Items]
Operating income by Segment
Operating income by segment
Corporate unallocated costs
Depreciation and amortization expense
Non-cash compensation through issuance of stock options
Interest expense and amortization of debt issuance costs
Change in fair value of derivative instruments
Amount owed to related party
Income tax benefit
Income tax rate
Series J Preferred Stock [Member]
Nature Of Goods And Services [Policy Text Block]
Indirect Sales to Wholesalers [Member]
Licensing [Member]
Unscheduled Products Licensing Fees [Member]
Unscheduled Products Manufacturing Fees [Member]
Scheduled Products Licensing Fees [Member]
Scheduled Products Manufacturing Fees [Member]
Disclosure of accounting policies recently issued accounting pronouncements not yet effective policy text block.
ANDA Acquisition Costs [Member]
Patent Application Costs [Member]
Accrued co-development profit split.
Accrued director dues.
Njeda Bonds Series A Notes [Member]
Njeda Bonds Series B Notes [Member]
Bonds payable gross.
Bonds payable current gross.
Long term bonds payable gross.
Bonds payable gross current.
Njeda Bonds Current [Member]
Njeda Bonds Noncurrent [Member]
NJEDA Bonds [Member]
Mortgage loan payable.
Mortgage Loan [Member]
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Nasrat Hakim CEO and Chairman [Member]
Davis Caskey [Member]
Debt Instrument Period [Axis]
Second Year [Member]
First Year [Member]
NBV Pompano Office Lease [Member]
140 Ludlow Lease [Member]
Water Equipment Lease [Member]
Finance lease option to purchase of asset.
Warehouse Equipment Lease [Member]
February 2024 Equipment Lease [Member]
Lease expiration date.
March 2024 Equipment Lease [Member]
July 2024 Equipment Lease [Member]
Other Lease [Member]
Schedule of Rent Expenses [Table Text Block]
Ludlow-144 [Member]
NBV-610 [Member]
Lease liability payments due next twelve months.
Lease liability payments due year two.
Lease liability payments due year three.
Lease liability payments due year four.
Lease liability undiscounted excess amount.
Lease liabilities.
Future minimum lease liabilities payments.
Schedule of weighted average remaining lease term and weighted average discount rate [Text Block]
Series J Convertible Preferred Stock [Member]
Convertible preferred stock stated value.
Convertible preferred stock par value per share.
Schedule of warrants measurement with unobservable inputs reconciliation recurring basis [Table Text Block]
2024 Equity Incentive Plan [Member]
2014 Equity Incentive Plan [Member]
Price difference between exercise price and quoted price.
Two Customers [Member]
Customer One [Member]
Customer Two [Member]
Customer Three [Member]
Three Customers [Member]
Purchases [Member]
Three Suppliers [Member]
Supplier One [Member]
Supplier Two [Member]
Supplier Three [Member]
Schedule of selected segment reporting information by reportable segment [Table Text Block]
Segment operating income (loss).
Corporate unallocated costs.
Related party agreements disclosure [Text Block]
Mikah Pharma LLC [Member]
Abbreviated New Drug Applications [Member]
Abbreviated New Drug Applications Revenue [Member]
Direct Sales to Wholesalers [Member]
Laboratory, Manufacturing, Warehouse and Transportation Equipment [Member]
Office Equipment and Software [Member]
Assets, Current
Other Assets
Assets
Liabilities, Current
Derivative Liability, Noncurrent
Liabilities, Noncurrent
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Depreciation, Depletion and Amortization
Stock or Unit Option Plan Expense
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Related Party Debt
Finance Lease, Principal Payments
Payments of Loan Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Net Income (Loss) Available to Common Stockholders, Diluted
Other Asset Impairment Charges
BondsPayableCurrentGross
Accumulated Amortization, Debt Issuance Costs
Debt Issuance Costs, Current, Net
Debt Issuance Costs, Noncurrent, Net
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Finance Lease, Liability, Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
Derivative Liability, Fair Value of Collateral
Derivative Liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Corporate unallocated costs
Interest and Debt Expense